When Are “Paraphernalia” Critical Medical Supplies
Datos Bibliográficos
| ID | 15747749 |
|---|---|
| Autores | Adriane M dela Cruz (0000-0002-2268-498X, Southwestern Medical Center, autor de correspondencia), Donald Egan (Southwestern Medical Center), Sarah E Baker (0000-0003-2257-2977, Southwestern Medical Center), John Z Sadler (0000-0003-1027-5174, Southwestern Medical Center) |
| Año | 2024 |
| Volumen | 26 |
| Número | 7 |
| Páginas | E527-533 |
| Fecha de publicación | 2024-07-01 |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | The AMA Journal of Ethic (JOURNAL) |
| Identificadores de la revista | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Editorial | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2024.527 |
| PMID | 38958421 |
| OpenAlex | W4400287983 |
| Idioma | EN |
| Referencias citadas | 4 |
Evidence of harm reduction interventions' morbidity and mortality benefits is abundant and of high quality, so there are good reasons for regional and national groups to advocate for more widespread distribution of legally regulated "drug paraphernalia," including needles, syringes, and fentanyl test strips. But lack of consistency among states' laws means that patients' interstate travel can subject them to being charged with possession of illegal items. This commentary on a case offers guidance to clinicians looking to help patients understand legal risks of interstate travel with supplies that are prescribed or recommended to reduce harms of their drug use and explores the ethical responsibilities of physicians in jurisdictions that legally prohibit these harm reduction interventions
Archaeology · Business · Geography · Paraphernalia · Pain Management and Placebo Effect
| Altamente citado | No |
|---|